US2010298233A1PendingUtilityA1
Compositions and methods related to profiling a plurality of cells based on peptide binding
Est. expiryMar 9, 2026(expired)· nominal 20-yr term from priority
C12N 15/1037C07K 7/64C07K 7/06A61P 35/00G01N 33/5759
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods and compositions are described for classifying cells and/or peptides that associate or bind with a particular characteristic pattern to a plurality of cells or cell lines. Aspects of the invention also include the use of peptide(s) having an appropriate binding characteristic to deliver a drug to a cell or cell population.
Claims
exact text as granted — not AI-modified1 . A method of profiling cell lines comprising:
a) providing a plurality of cell lines; b) contacting each cell line with a library of phage displaying random heterologous peptides on their surface; c) obtaining phage that bind each of the cell lines; d) identifying peptides that bind each cell line; and e) classifying each cell line based on the identified peptides.
2 . The method of claim 1 , further comprising classifying each identified peptide based on the cell lines that bind each identified peptide.
3 . The method of claim 1 , wherein the panel includes cancer cell lines.
4 . The method of claim 3 , wherein the cancer cell lines include kidney, breast, colon, lung, prostate, brain, liver, pancreatic, uterine, neuronal, skin, head and neck, leukemic, lymphocytic, or ovarian cancer cell lines.
5 . The method of claim 3 , wherein the panel is cancer cell lines.
6 . The method of claim 5 , wherein the panel is a NCI 60 panel of cancer cell lines.
7 . The method of claim 3 , further comprising identifying a peptide that binds to a majority of the cancer cell lines or cancer cells of common origin.
8 . The method of claim 1 , further comprising analyzing the identified peptides to identify similarities with known receptor ligands.
9 . The method of claim 1 , wherein classifying the cell line is performed by clustering analysis.
10 . The method of claim 9 , wherein the clustering analysis is used to construct a clustered image map.
11 . The method of claim 2 , wherein classifying the identified peptide is performed by clustering analysis.
12 . The method of claim 11 , wherein the clustering analysis is used to construct a clustered image map.
13 . The method of claim 1 , further comprising identifying receptors for at least one of the identified peptides comprising the steps of:
a) providing an identified peptide; b) labeling the identified peptide; c) contacting an appropriate cell line with the labeled peptide; d) isolating a receptor-peptide complex; and e) identifying the receptor bound to the labeled peptide.
14 . A group of peptides comprising five or more peptides that selectively bind to a sub-population of cell lines, wherein the peptides comprise those listed in Table 3.
15 . A method of classifying a cell or cell line comprising:
a) contacting the cell with a group of selected peptides or polypeptides that differentially bind cells of a known origin; b) detecting the peptides or polypeptides that bind the cell line; and c) assessing the classification of the cell or cell line based on the peptide(s) that bind the cell.
16 . The method of claim 15 , wherein the selected peptides or polypeptides are phage particles.
17 . The method of claim 15 , wherein the selected peptides or polypeptides are labeled.
18 . The method of claim 175 , wherein the selected peptides or polypeptides are labeled with a fluorophor, an enzyme or a radioisotope.
19 . The method of claim 15 , wherein the group of selected peptides or polypeptides comprise at least 3 different peptides or polypeptides.
20 . The method of claim 15 , wherein the selected peptides or polypeptides comprise are cyclic.
21 . The method of claim 15 , wherein the selected peptides or polypeptides comprise at least 3 of the amino acid sequences from Table 3.
22 . The method of claim 15 , wherein the cell or cell line is a cancer cell or cancer cell line.
23 . The method of claim 15 , wherein classifying a cell comprises determineing the tissue origin of the cell or whether the cell expresses a particaulr receptor.
24 . The method of claim 15 , wherein classifying a cell comprises determineing wether the cell is resistant to an anti cancer therapy.
25 . The method of claim 15 , wherein the selected peptides or polypeptides differentially bind to a panel of cells of a known origin.
26 . A method of classifying a peptide comprising:
a) contacting a plurality of cell lines with a library of peptides that differentially bind the cells; b) detecting the peptides that bind the cell line; and c) classifying the peptides based on the cells that bind the peptide.
27 . An EphA5 receptor targeting peptide comprising a peptide sequence of CSGIGSGGC or CRFESSGGC.
28 . The peptide of claim 27 , wherein the peptide is cyclic.
29 . The peptide of claim 27 , further comprising a therapeutic.
30 . The peptide of claim 29 , wherein the therapeutic is a small molecule or a therapeutic polypeptide.
31 . The peptide of claim 27 , further comprising an imaging agent.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.